ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ACSM1 | Acyl-CoA synthetase medium-chain family member 1 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1D | Adrenoceptor alpha 1D | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AGBL1 | ATP/GTP binding protein-like 1 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
ALDH1A3 | Aldehyde dehydrogenase 1 family, member A3 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
ALOX15B | Arachidonate 15-lipoxygenase, type B | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
ALX4 | ALX homeobox 4 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
ANO7 | Anoctamin 7 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARHGAP6 | Rho GTPase activating protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARHGEF38 | Rho guanine nucleotide exchange factor (GEF) 38 | | | | | | Tissue enhanced |
ASTN2 | Astrotactin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BMPR1B | Bone morphogenetic protein receptor, type IB | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
C7orf63 | Chromosome 7 open reading frame 63 | | | | | | Tissue enhanced |
C9orf92 | Chromosome 9 open reading frame 92 | Predicted membrane proteins
| | | | | Tissue enhanced |
CCDC183 | Coiled-coil domain containing 183 | | | | | | Tissue enhanced |
CDH26 | Cadherin 26 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLUL1 | Clusterin-like 1 (retinal) | Predicted secreted proteins
| | | | | Tissue enhanced |
COL13A1 | Collagen, type XIII, alpha 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
COL2A1 | Collagen, type II, alpha 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
COL9A1 | Collagen, type IX, alpha 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CPA6 | Carboxypeptidase A6 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CPLX3 | Complexin 3 | | | | | | Tissue enhanced |
CPNE4 | Copine IV | | | | | | Tissue enhanced |
CRISPLD1 | Cysteine-rich secretory protein LCCL domain containing 1 | Plasma proteins
| | | | | Tissue enhanced |
CWH43 | Cell wall biogenesis 43 C-terminal homolog (S. cerevisiae) | Predicted membrane proteins
| | | | | Tissue enhanced |
EVX1 | Even-skipped homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
EVX2 | Even-skipped homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
EYA1 | Eyes absent homolog 1 (Drosophila) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
FEV | FEV (ETS oncogene family) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FOXA1 | Forkhead box A1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
GABRG3 | Gamma-aminobutyric acid (GABA) A receptor, gamma 3 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GATA2 | GATA binding protein 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
GCSAML | Germinal center-associated, signaling and motility-like | | | | | | Tissue enhanced |
GJC3 | Gap junction protein, gamma 3, 30.2kDa | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLB1L3 | Galactosidase, beta 1-like 3 | | | | | | Tissue enhanced |
GLIS1 | GLIS family zinc finger 1 | Transcription factors
| | | | | Tissue enhanced |
GUCY2D | Guanylate cyclase 2D, membrane (retina-specific) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
HIST1H2AD | Histone cluster 1, H2ad | | | | | | Tissue enhanced |
HIST1H2AE | Histone cluster 1, H2ae | | | | | | Tissue enhanced |
HIST1H2BF | Histone cluster 1, H2bf | Plasma proteins
| | | | | Tissue enhanced |
HIST1H4E | Histone cluster 1, H4e | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
HIST2H2AA3 | Histone cluster 2, H2aa3 | | | | | | Tissue enhanced |
HIST2H2BF | Histone cluster 2, H2bf | | | | | | Tissue enhanced |
IRX4 | Iroquois homeobox 4 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ISL1 | ISL LIM homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
KCNH6 | Potassium voltage-gated channel, subfamily H (eag-related), member 6 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
LRRC24 | Leucine rich repeat containing 24 | Predicted membrane proteins
| | | | | Tissue enhanced |
LY6G6D | Lymphocyte antigen 6 complex, locus G6D | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |